About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Cognitive Reappraisal in Adolescents With Major Depression

Cognitive Reappraisal in Adolescents With Major Depression

NCT03957850·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ludwig-Maximilians - University of Munich

With

German Research Foundation
RWTH Aachen University
University of Amsterdam

Age

12–18

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Female and male participants
age range: 12-18 years
current diagnosis of MD (ICD-10 diagnoses F32.0; F32.1; F32.2, F33.0, F33.1, F.33.2)
intelligence quotient (IQ) of ≥ 80

You may not be if

neurological disorders
schizophrenic disorder
pervasive developmental disorder
bipolar disorder
borderline personality disorder
substance dependence disorder
gender dysphoria.
Participants comorbid with psychiatric comorbidities other than those listed above are included if MD is the primary diagnosis.

The record

StatusCompleted

PhaseNo phase

Taking part71

StartedMay 2019

UpdatedAug 23, 2022

Conditions

Major Depressive Disorder

Where1

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Munich, Munich, Germany
Munich, Bavaria, Germany